
    
      The trial will be conducted in patients with any form of Epidermolysis Bullosa (EB) with at
      least 1 active EB wound between 2.5 and 50 cm2 in size or up to 10% of the Body Surface Area.
      The investigators will identify an "index lesion" and other lesions for treatment An area of
      un-involved skin will also be treated with the study cream. This are will be used for testing
      by producing tiny blisters th so that the underlying tissue can be examined using a special
      microscope.

      Patients will apply the study cream
    
  